Disease association of the CD103 polymorphisms in Taiwan Chinese Graves' ophthalmopathy patients

Ophthalmology

Volumn 117, Issue 8, 2010, Pages 1645-1651

  Liu, Yu Huei ^a,b   Chen, Rong Hsing ^b   Chen, Wen Chi ^b   Tsai, Yuhsin ^b   Wan, Lei ^a,b,c   Tsai, Fuu Jen ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; GENOMIC DNA;

ADULT; ARTICLE; CHINESE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA POLYMORPHISM; ENDOCRINE OPHTHALMOPATHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; GOITER; GRAVES DISEASE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYXEDEMA; NODULAR HYPERPLASIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; VITILIGO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GRAVES OPHTHALMOPATHY; HUMANS; INTEGRIN ALPHA CHAINS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN; YOUNG ADULT;

EID: 77955468127     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.12.037     Document Type: Article

References (44)

1. L.C. Eisenlohr, and J.L. Rothstein Oncogenic inflammation and autoimmune disease Autoimmun Rev 6 2006 107 114
2. P.A. Ward Cytokines, inflammation, and autoimmune diseases Hosp Pract (Minneap) 30 1995 35 41
3. E.Y. Kim, and K.D. Moudgil Regulation of autoimmune inflammation by pro-inflammatory cytokines Immunol Lett 120 2008 1 5
4. J.R. Wall Graves' disease is a multi-system autoimmune disorder in which extra ocular muscle damage and connective tissue inflammation are variable features Thyroid 12 2002 35 36
5. G.M. Lehmann, S.E. Feldon, T.J. Smith, and R.P. Phipps Immune mechanisms in thyroid eye disease Thyroid 18 2008 959 965
6. R.S. Bahn Clinical review 157: pathophysiology of Graves' ophthalmopathy: the cycle of disease J Clin Endocrinol Metab 88 2003 1939 1946
7. A.G. Gianoukakis, N. Khadavi, and T.J. Smith Cytokines, Graves' disease, and thyroid-associated ophthalmopathy Thyroid 18 2008 953 958
8. A. Mishra, and S.K. Mishra Multicentre study of thyroid nodules in patients with Graves' disease (Br J Surg 2000;87:1111-13) [letter] Br J Surg 88 2001 313
9. P. Perros, C. Neoh, and J. Dickinson Thyroid eye disease [online report] BMJ 338 2009 b560
10. A.E. Kuriyan, R.P. Phipps, and S.E. Feldon The eye and thyroid disease Curr Opin Ophthalmol 19 2008 499 506
11. T.K. Khoo, and R.S. Bahn Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies Thyroid 17 2007 1013 1018
12. S. Kloprogge, L. Kowal, J. Wall, and A.G. Frauman The clinicopathologic basis of Graves' ophthalmopathy: a review Eur J Ophthalmol 15 2005 315 323
13. L. Bartalena Glucocorticoids for Graves' ophthalmopathy: how and when [editorial] J Clin Endocrinol Metab 90 2005 5497 5499
14. T. Bednarczuk, B. Gopinath, R. Ploski, and J.R. Wall Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 67 2007 3 19
15. J.P. Banga, C.H. Nielsen, and J.A. Gilbert, et al. Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials Thyroid 18 2008 973 981
16. A. Esteghamati, O. Khalilzadeh, and Z. Mobarra, et al. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients Eur J Intern Med 20 2009 424 428
17. O. Khalilzadeh, H. Mojazi Amiri, and M. Tahvildari, et al. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy Arch Dermatol Res 301 2009 719 723
18. A.A. Syed, M.J. Simmonds, and O.J. Brand, et al. Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy Clin Endocrinol (Oxf) 67 2007 663 667
19. Y. Hiromatsu, T. Fukutani, and M. Ichimura, et al. Interleukin-12B gene polymorphism does not confer susceptibility to Graves' ophthalmopathy in Japanese population Endocr J 53 2006 753 759
20. S.Z. Han, S.H. Zhang, and R. Li, et al. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients Int J Immunogenet 33 2006 281 287
21. T. Bednarczuk, A. Kurylowicz, and Y. Hiromatsu, et al. Association of G-174C polymorphism of the interleukin-6 gene promoter with Graves' ophthalmopathy Autoimmunity 37 2004 223 226
22. T. Bednarczuk, Y. Hiromatsu, and T. Fukutani, et al. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations Eur J Endocrinol 148 2003 13 18
23. A. Petrone, G. Giorgi, and A. Galgani, et al. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population Thyroid 15 2005 232 238
24. Y. Jin, C.M. Mailloux, and K. Gowan, et al. NALP1 in vitiligo-associated multiple autoimmune disease N Engl J Med 356 2007 1216 1225
25. J.M. Olson, Y. Song, and D.M. Dudek, et al. A genome screen of systemic lupus erythematosus using affected-relative-pair linkage analysis with covariates demonstrates genetic heterogeneity Genes Immun 3 suppl 2002 S5 S12
26. N.E. Bufalo, R.B. Santos, and A.N. Cury, et al. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease Clin Endocrinol (Oxf) 68 2008 982 987
27. A.D. McLellan, M. Kapp, and A. Eggert, et al. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression Blood 99 2002 2084 2093
28. W.W. Agace, J.M. Higgins, and B. Sadasivan, et al. T-lymphocyte- epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines Curr Opin Cell Biol 12 2000 563 568
29. L.J. Smyth, J.A. Kirby, and A.C. Cunningham Role of the mucosal integrin alpha(E)(CD103)beta(7) in tissue-restricted cytotoxicity Clin Exp Immunol 149 2007 162 170
30. N.E. Annels, A.J. Willemze, and V.H. van der Velden, et al. Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL Blood 103 2004 2806 2808
31. A. Le Floc'h, A. Jalil, and I. Vergnon, et al. Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis J Exp Med 204 2007 559 570
32. R. El-Asady, R. Yuan, and K. Liu, et al. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease J Exp Med 201 2005 1647 1657
33. M.P. Schon, M. Schon, and H.B. Warren, et al. Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice J Immunol 165 2000 6583 6589
34. O. Annacker, J.L. Coombes, and V. Malmstrom, et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis J Exp Med 202 2005 1051 1061
35. A. Banz, A. Peixoto, and C. Pontoux, et al. A unique subpopulation of CD4+ regulatory T cells controls wasting disease, IL-10 secretion and T cell homeostasis Eur J Immunol 33 2003 2419 2428
36. A. Hanninen, M. Salmi, O. Simell, and S. Jalkanen Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior Diabetes 45 1996 1173 1180
37. Y. Feng, D. Wang, and R. Yuan, et al. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells J Exp Med 196 2002 877 886
38. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
39. Y. Tomer, and T.F. Davies Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function Endocr Rev 24 2003 694 717
40. H. Ayadi, H. Hadj Kacem, A. Rebai, and N.R. Farid The genetics of autoimmune thyroid disease Trends Endocrinol Metab 15 2004 234 239
41. M.R. Velaga, V. Wilson, and C.E. Jennings, et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease J Clin Endocrinol Metab 89 2004 5862 5865
42. N. Manji, J.D. Carr-Smith, and K. Boelaert, et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype J Clin Endocrinol Metab 91 2006 4873 4880
43. S.H. Acharya, A. Avenell, and S. Philip, et al. Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review Clin Endocrinol (Oxf) 69 2008 943 950
44. B. Rapoport, R. Alsabeh, D. Aftergood, and S.M. McLachlan Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease Thyroid 10 2000 685 692